The Global antihypertensive drug Market was valued at USD 29.7 billion in 2020, and it is expected to reach USD 34.1 billion by 2027, with a CAGR of 2.1%, during the forecast period (2021-2027).
Hypertension is one of the most common condition people are facing across the globe. Hypertension is the condition caused by increase in systolic blood pressure on the walls of arteries. Excessive increase in blood pressure case vessels rupture and have high chances of causing serious health issues. The factors that contribute to the growth of antihypertensive drug market are the increase in rate of cardiovascular diseases, kidney failures which are affected by external factors like stress level, work-life balance, diet etc. Increase in geriatric patients has also show effect on the Antihypertensive drug market growth. Due Covid-19, the growth of antihypertensive drug market was hindered due to less cardio-patients and in-patients related to heart diseases.
According to researchers, Age is one of the primary factors that lead to hypertension. It is proved that prevalence of causing hypertension to age group above 60 is higher. Aging is directly proportional to the increase in blood pressure as with age the elastic nature of blood vessels decreases and pressure of blood increases. Therefore, age stood to be important factor for increase in antihypertensive drug market share over period of time.
The government initiative includes the program which will be conducted by Indian Council of Medical Research in collaboration with WHO and Ministry of Health and Family welfare. This will be initiated for providing quality care for hypertension patients of more than 15 crore population for about coming four years and to decrease the number of deaths due to heart failure, Kidney failure. Such awareness camps will help people to understand the seriousness of hypertension and this will ultimately help to increase the market share of antihypertensive drugs and this will affect the growth of antihypertensive drug market.
The Global Antihypertensive Drug Market Segmentation:
By Drug Category type
By Distribution channel
By Geographical region
The unique insights provided by this report also includes the following:
Based on drug category type, calcium channel blocker drugs are expected to increase the market share of antihypertensive drug and continue to grow with forecast period 2027
Antihypertensive drugs are broadly classified into different categories based on their route of action like calcium channel blockers, alpha blockers, beta blockers, ACE inhibitors etc. The most commonly prescribed drug category is diuretics and calcium channel blockers. As it is researched that, many renal related or kidney problems give rise to hypertension like condition. Moreover, Thiazide diuretics are considered to be one of the most commonly prescribed medication to the patients and this stood to stimulate the Antihypertensive drug market.
A part from diuretics, another most widely prescribed drug category is calcium channel blockers, as it accounts less side effects than other category drugs.
Based on distribution channel, hospital pharmacy is expected to occupy the highest Antihypertensive drug market share
There are different channels of distribution like retail shops, hospital pharmacies and newly e-commerce shops. As antihypertensive drugs are prescribed drugs, mostly prescribed by the healthcare specialist from the hospitals and this gives rise to increase in market share of drugs through hospital pharmacy channel. On the other side, due to pandemic, e-commerce is expected to have highest market growth rate during forecast period 2021-2027, owing the availability of access of internet across the world.
Based on geographical region, North America dominated the market in 2020 and this is expected to maintain dominance during forecast period.
American Heart Association predicted that there are 75% of American population who are currently undergoing the hypertension treatment and about 53% patients could recover and are under control. They also projected that in coming years by 2030, there will approximately 42% of population to use antihypertensive drugs. North America also has ease supply of antihypertensive drugs which would lead to continue and increase in coming years. Asia- Pacific is expected to show high growth during antihypertensive drug forecast period due to increase in awareness and health consciousness with the populations.
Company Profiles and Competitive Intelligence: Novartis AG (Switzerland), Merck KGaA (Germany), United Therapeutics Corporation (U.S.), Bayer AG (Germany), Pfizer, Inc. (U.S.), Sanofi S.A. (France), AstraZeneca (U.K.), Daiichi Sankyo Company, Ltd. (Japan), Johnson and Johnson Services, Inc. (U.S.), Boehringer Engelheim GmbH (Germany), and Takeda Pharmaceutical Company (Japan)are some of the major players in the global antihypertensive drugs market.
The report also provides in-depth analysis of antihypertensive drug market dynamics such as drivers, restraints opportunities and challenges
Drivers
Restraints
Opportunities
Challenges
COVID-19 Impact on the antihypertensive drug Market Analysis
This covid outbreak has drastically affected the healthcare industry. The measures that were taken to control the cases like lockdown, social distancing led to affect the production and manufacturing of the drugs. There was significant decrease in heart related surgeries, less in patients, and limitation to the hospital consulting; all these factors collectively affected the market share of antihypertensive drugs. Doctors and researchers showed that after some period of time, covid patient’s show complications related to cardiovascular. Looking at this scenario, health care professionals has given permission for the use of cardiovascular drugs irrespective to covid. Hence, there is sudden increase in market of cardiovascular drugs and antihypertensive drug market.
The report also provides in-depth analysis of key trends in Antihypertensive drugs market
| Sr. No. | Trends | Impact |
| 1 | Due to Covid-19, there has been very slow growth of hypertensive drug in the market which had poor effect on covid patients. | Negative |
| 2 | The New drugs in pipeline and inventions impact on antihypertensive drug market | Positive |
The report also provides in-depth analysis of recent news developments and investments associated with antihypertensive drug market
Company Profiles and Competitive Intelligence
The key players operating in the market are:
Ask for free product review call with the author
Share your specific research requirements for a customized report
Request for due diligence and consumer centric studies
Request for study updates, segment specific and country level reports
6.3 Asia Pacific
6.3.1 China
6.3.2 India
6.3.3 Japan
6.3.4Rest Of Asia Pacific
6.4 Latin America
6.5 Middle East and Africa
10.1 Merck KGaA (Germany)
10.2 Johnson and Johnson Services, Inc. (U.S.)
10.3 Bayer AG (Germany)
10.4 Pfizer Inc. (U.S.),
10.5 United Therapeutics Corporation (U.S.)
10.6 Sanofi S.A. (France)
10.7 Novartis AG (Switzerland)
10.8 AstraZeneca (U.K.)
10.9 Takeda Pharmaceutical Company (Japan)
Log in / Register
